Statistics
Publications
1
Citations
341
H-Index
1
Active since
2020
Affiliations
H. Rizvi is an author at Memorial Sloan Kettering Cancer Center specializing in immune checkpoint inhibitors, programmed death-ligand 1 inhibition, and tumor antigens.
Publications per year
2020–2020
1
1
Clinical and molecular correlates of PD-L1 expression in patients with lung adenocarcinomas
A.J. Schoenfeld, H. Rizvi, Chai Bandlamudi et al. · Annals of Oncology · 2020 · 341 citations · Full text
1–1 of 1